We are live on ! Find out more
ACM

AlphaCrest Capital Management Portfolio holdings

AUM $1.64B
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
+4.34%
1 Year Est. Return
-23.4%
3 Year Est. Return
-8.44%
5 Year Est. Return
10 Year Est. Return
AUM
$2.33B
AUM Growth
+$532M
Cap. Flow
+$466M
Cap. Flow %
20.05%
Top 10 Hldgs %
5.87%
Holding
1,402
New
244
Increased
583
Reduced
375
Closed
199

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$17.3M
2
NKE icon
Nike
NKE
+$16.2M
3
MRK icon
Merck
MRK
+$13.4M
4
CMCSA icon
Comcast
CMCSA
+$12.8M
5
MSFT icon
Microsoft
MSFT
+$9.26M

Sector Composition

Rank Sector Weight
1 Technology 19.18%
2 Financials 14.64%
3 Healthcare 14.37%
4 Industrials 13.29%
5 Consumer Discretionary 10.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BURL icon
501
Burlington
BURL
$23.2B
$1.41M 0.06%
4,372
-350
-7% -$111K
VMI icon
502
Valmont Industries
VMI
$9.44B
$1.41M 0.06%
+5,963
New +$1.44M
HLI icon
503
Houlihan Lokey
HLI
$8.51B
$1.4M 0.06%
17,172
-23,828
-58% -$1.73M
ZUMZ icon
504
Zumiez
ZUMZ
$341M
$1.4M 0.06%
28,504
+12,159
+74% +$546K
APD icon
505
Air Products & Chemicals
APD
$65.2B
$1.39M 0.06%
4,843
-1,099
-18% -$323K
IDCC icon
506
InterDigital
IDCC
$7.85B
$1.39M 0.06%
+19,053
New +$1.41M
EXEL icon
507
Exelixis
EXEL
$13.5B
$1.39M 0.06%
76,200
+61,323
+412% +$1.43M
KURA icon
508
Kura Oncology
KURA
$809M
$1.38M 0.06%
66,300
+38,800
+141% +$963K
FATE icon
509
Fate Therapeutics
FATE
$295M
$1.38M 0.06%
15,893
+12,866
+425% +$1.04M
BKR icon
510
Baker Hughes
BKR
$59.8B
$1.38M 0.06%
60,133
+7,723
+15% +$178K
CSOD
511
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$1.38M 0.06%
26,660
-23,565
-47% -$1.09M
QDEL icon
512
QuidelOrtho
QDEL
$1.17B
$1.37M 0.06%
10,715
-5,598
-34% -$659K
MANH icon
513
Manhattan Associates
MANH
$11.1B
$1.37M 0.06%
+9,448
New +$1.26M
BIG
514
DELISTED
Big Lots, Inc.
BIG
$1.37M 0.06%
20,725
+15,979
+337% +$1.06M
FHN icon
515
First Horizon
FHN
$12.2B
$1.37M 0.06%
79,110
+45,347
+134% +$823K
XRX icon
516
Xerox
XRX
$429M
$1.36M 0.06%
57,930
-30,992
-35% -$749K
ZUO
517
DELISTED
Zuora, Inc.
ZUO
$1.36M 0.06%
78,891
+21,791
+38% +$348K
LEA icon
518
Lear
LEA
$6.44B
$1.35M 0.06%
+7,723
New +$1.43M
NSP icon
519
Insperity
NSP
$2.03B
$1.35M 0.06%
14,983
+1,358
+10% +$121K
OLN icon
520
Olin
OLN
$2.15B
$1.35M 0.06%
29,259
+22,085
+308% +$994K
POOL icon
521
Pool Corp
POOL
$7.01B
$1.35M 0.06%
2,952
-4,157
-58% -$1.75M
MSM icon
522
MSC Industrial Direct
MSM
$6.99B
$1.34M 0.06%
14,957
+1,139
+8% +$104K
CBSH icon
523
Commerce Bancshares
CBSH
$8.58B
$1.34M 0.06%
22,963
-10,490
-31% -$632K
ACAD icon
524
Acadia Pharmaceuticals
ACAD
$4.4B
$1.34M 0.06%
54,805
+13,601
+33% +$307K
MAT icon
525
Mattel
MAT
$4.39B
$1.33M 0.06%
66,425
-31,892
-32% -$659K

Similar funds

AlphaCrest Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, AlphaCrest Capital Management held 1,402 positions worth $2.33B, up 30% from $1.79B the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.

AlphaCrest Capital Management deployed $466M of net new capital in Q2 2021, opening 244 new positions and adding to 583 existing holdings. Its largest new stake was Nucor: 85,982 shares worth $8.25M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Morgan Stanley, an estimated $17.3M trimmed.

  • AlphaCrest Capital Management's largest Q2 2021 buy was Nucor: 85,982 shares worth $8.25M.
  • AlphaCrest Capital Management added most to Fiserv Inc in Q2 2021, an estimated $12.3M increase.
  • AlphaCrest Capital Management's biggest Q2 2021 reduction was Morgan Stanley, cutting an estimated $17.3M.
  • AlphaCrest Capital Management fully exited Merck in Q2 2021, selling an estimated $13.4M.
  • AlphaCrest Capital Management's ten largest holdings make up 5.9% of its $2.33B portfolio in Q2 2021.
  • AlphaCrest Capital Management opened 244 new positions and closed 199 in Q2 2021.
  • AlphaCrest Capital Management's portfolio value rose 30% quarter-over-quarter to $2.33B.

Based on AlphaCrest Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.